A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II,National Research Council
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II,National Research Council
National Research Council of the National Academies.
This item is not currently in-stock. It can be ordered online and is expected to ship in approx 4 weeks
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.